1. Home
  2. GOGO vs CCCC Comparison

GOGO vs CCCC Comparison

Compare GOGO & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gogo Inc.

GOGO

Gogo Inc.

HOLD

Current Price

$3.35

Market Cap

461.2M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.27

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOGO
CCCC
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
461.2M
404.7M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
GOGO
CCCC
Price
$3.35
$4.27
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$15.00
$12.20
AVG Volume (30 Days)
2.4M
2.4M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
0.10
N/A
Revenue
$910,491,000.00
$35,947,000.00
Revenue This Year
$3.68
N/A
Revenue Next Year
$3.60
N/A
P/E Ratio
$33.10
N/A
Revenue Growth
104.74
1.02
52 Week Low
$3.23
$1.40
52 Week High
$16.82
$4.60

Technical Indicators

Market Signals
Indicator
GOGO
CCCC
Relative Strength Index (RSI) 35.26 62.91
Support Level $3.29 $2.10
Resistance Level $4.92 $4.60
Average True Range (ATR) 0.27 0.37
MACD -0.04 0.00
Stochastic Oscillator 10.81 77.88

Price Performance

Historical Comparison
GOGO
CCCC

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped. Geographically, it operates in United States; and International as well.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: